Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
- PMID: 37663232
- PMCID: PMC10473459
- DOI: 10.1515/med-2023-0760
Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
Abstract
Low molecular weight heparin (LMWH) is often used to prevent perioperative venous thrombosis after surgery, but aspirin is also recommended by academics. Studies were searched in electronic databases until February 24, 2023. We performed a meta-analysis to evaluate the safety and efficacy of aspirin and LMWH for venous thromboembolism (VTE) prophylaxis in patients after orthopedic surgery. The outcomes were death from any causes, deep vein thrombosis (DVT), pulmonary embolism (PE), etc. This study was registered with INPLASY, number 202320117. Six randomized controlled trials enrolled 13,851 patients with postoperative joint surgery. The risk of DVT was comparable between the two groups when aspirin was combined with mechanical devices (RR 0.61 [95% CI 0.27-1.39], I² = 62%, P = 0.24). No significant differences in all cause death, PE, wound infection, and wound complication were found between the aspirin and LMWH groups. In this meta-analysis, the mortality rate was comparable between the aspirin and LMWH groups. However, aspirin alone had a higher risk of DVT than LMWH. Based on the results of this meta-analysis, we suggest aspirin combined with mechanical devices for VTE prophylaxis in patients after orthopedic surgery.
Keywords: aspirin; joint surgery; low-molecular-weight heparin; venous thromboembolism.
© 2023 the author(s), published by De Gruyter.
Conflict of interest statement
Conflict of interest: Authors state no conflict of interest.
Figures
Similar articles
-
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.Cochrane Database Syst Rev. 2020 May 6;5(5):CD005259. doi: 10.1002/14651858.CD005259.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Aug 22;8:CD005259. doi: 10.1002/14651858.CD005259.pub5. PMID: 32374919 Free PMC article. Updated.
-
Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis.Blood Coagul Fibrinolysis. 2024 Jun 1;35(4):187-195. doi: 10.1097/MBC.0000000000001300. Epub 2024 Apr 18. Blood Coagul Fibrinolysis. 2024. PMID: 38652521 Free PMC article.
-
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jun. Report No.: 17-EHC021-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jun. Report No.: 17-EHC021-EF. PMID: 29389096 Free Books & Documents. Review.
-
The efficacy of aspirin compared to low molecular weight heparin as thromboprophylaxis after orthopedic surgery: A systematic review and meta-analysis.Phlebology. 2025 Mar 13:2683555251325415. doi: 10.1177/02683555251325415. Online ahead of print. Phlebology. 2025. PMID: 40080857 Review.
-
No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.J Arthroplasty. 2021 Oct;36(10):3589-3592. doi: 10.1016/j.arth.2021.06.001. Epub 2021 Jun 10. J Arthroplasty. 2021. PMID: 34176693
References
Publication types
LinkOut - more resources
Full Text Sources